Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gwangju
Clinical trial register · South Korea

Clinical Trials in Gwangju, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 2821 Daegu 554 Seongnam-si 493 Busan 468 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC17 Chonnam National University Hospital14 Eli Lilly and Company11 Novartis Pharmaceuticals11 Samsung Medical Center10
Site location
Seoul2821 Daegu554 Seongnam-si493 Busan468 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Gwangju

206 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Gwangju, Seoul
2026-11-09
Not yet open
Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke
NCT07730840Ischemic Stroke, Transient Ischemic Attack
DrugZastaprazan
Asan Medical Center
Phase 3
984
Daejeon, Gwangju, Gyeonggi-do, Incheon, Jeju City, Jeonju, Seoul
2026-10-15
Not yet open
Optimal Timing of Microaxial Flow Pump(Impella CP) in AMI-related Cardiogenic Shock
NCT07817472Myocardial Infarction (MI), Cardiogenic Shock, ST-Segment Elevation Myocardial Infarction(STEMI), Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
Chonnam National University Hospital
Not applicable
126
Gwangju
2026-10-01
Active, closed
Gwangju Health University
Not applicable
36
Gwangju
2026-09-10
Not yet open
Chonnam National University Hospital
Not applicable
1,252
Bucheon-si, Changwon, Cheonan, Cheongju-si, Chuncheon, Daegu, Daejeon, Gwangju
2026-09-01
Recruiting
Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI
NCT07583784Myocardial Infarction (MI), ST-Segment Elevation Myocardial Infarction(STEMI), NSTEMI - Non-ST-Segment Elevation Myocardial Infarction, AF - Atrial Fibrillation
DrugsDOAC·Clopidogrel
Chonnam National University Hospital
Not applicable
860
Gwangju
2026-08-26
Recruiting
Eli Lilly and Company
Phase 3
2,001
Ansan-si, Anyang-si, Busan, Guri-si, Gwangju, Junggu, Seogu, Seongnam
2026-08-26
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongbuk-Gu, Seoul
2026-08-24
Recruiting
Eli Lilly and Company
Phase 3
1,000
Ansan-si, Gwangju, Jeju City, Seoul
2026-08-14
Not yet open
Seoul National University Hospital
Not applicable
1,724
Ansan, Anyang, Busan, Changwon, Cheonan, Daegu, Gwangju, Incheon
2026-07-29
Recruiting
Novartis Pharmaceuticals
Phase 3
570
Gwangju, Seoul
2026-07-16
Recruiting
AstraZeneca
Phase 3
2,000
Goyang-si, Guri-si, Gwangju, Gyeonggi-do, Seoul, Yangsan
2026-07-06
Recruiting
Sanofi
Observational
706
Busan, Daegu, Goyang, Gwangju, Hanam, Iksan, Seongnam, Seoul
2026-07-01
Recruiting
Novo Nordisk A/S
Phase 2
300
Gwangju, Seoul
2026-06-22
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
150
Wŏnju, Gwangju, Bucheon-si, Seoul
2026-06-02
Not yet open
Chonnam National University Hospital
Not applicable
512
Gwangju
2026-05-31
Recruiting
Transition of Care in Pediatric Rare Endocrine Disorders
NCT07786142Endocrine Disorder, Rare Disorders
Seoul National University Hospital
Not applicable
150
Daegu, Daejeon, Gwangju, Hwasun, Incheon, Jeonju, Seongnam, Seoul
2026-05-20
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Daegu, Wŏnju, Bundang Gu, Suwon, Incheon, Seoul, Busan, Gwangju
2026-05-11
Recruiting
Inhibikase Therapeutics
Phase 3
486
Gwangju, Seoul
2026-04-23
Recruiting
LEXURE for Post-Stroke Aphasia
NCT07570264Aphasia
Nunaps Inc
Not applicable
116
Ansan, Busan, Chuncheon, Daegu, Gwangju, Ilsan, Jeonju, Seoul
2026-04-16
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
648
Daegu, Hwaseong-si, Suwon, Dongjak Gu, Seoul, Gwangju, Incheon
2026-04-16
Recruiting
Novo Nordisk A/S
Phase 3
630
Seoungnam-si, Gwangju, Seoul
2026-04-13
Recruiting
The DECISION-CTO Extended 10 Y Follow-up
NCT06908499Coronary Artery Disease
Seung-Jung Park
Observational
840
Anyang, Bucheon-si, Busan, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2026-04-01
Recruiting
Eisai Co., Ltd.
Phase 2
256
Daegu, Gwangju
2026-03-31
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Busan, Daegu, Daejeon, Gwangju, Gyeongsan-si, Pusan, Seoul, Wŏnju
2026-03-26
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Seongnam-si, Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Seoul
2026-03-23
Recruiting
Samsung Medical Center
Not applicable
2,100
Seoul, Busan, Changwon, Daegu, Gwangju, Gwangmyeong, Gyeonggi-do, Iksan
2026-03-18
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Daegu, Seongnam-si, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seoul
2026-03-16
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Busan, Gwangju, Gyeonggi-do, Seoul, Suwon
2026-03-05
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Cheongju-si, Gwangju, Incheon, Seoul, Wŏnju
2026-03-03
Not yet open
Doxycycline vs. Macrolide for MRMP (DOMINO)
NCT07306234Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia
DrugsDoxycycline·Azithromycin
Young June Choe
Phase 4
208
Busan, Changwon, Gwangju, Jeju City, Seongnam, Seoul
2026-03-01
Recruiting
Chonnam National University Hospital
Observational
15,000
Gwangju
2026-03-01
Not yet open
Korea Acute Myocardial Infarction Registry
NCT07409441Myocardial Infarction, Acute
Samsung Medical Center
Observational
20,000
Gwangju, Seoul
2026-03-01
Active, closed
Ajou University School of Medicine
Not applicable
45
Seongnam-si, Suwon, Busan, Gwangju
2026-02-23
Recruiting
ViiV Healthcare
Phase 2
186
Daegu, Gwangju, Pusan, Seoul
2026-02-11
Recruiting
Eli Lilly and Company
Phase 3
1,000
Ansan-si, Gwangju, Jeju City, Seoul
2026-02-09
Recruiting
Sanofi
Phase 3
751
Busan, Gwangju, Seoul
2026-01-22
Recruiting
Eli Lilly and Company
Phase 3
1,035
Ansan-si, Guri-si, Gwangju, Seongnam, Seoul
2025-12-15
Recruiting
Boehringer Ingelheim
Phase 3
120
Daegu, Gwangju, Seongnam, Seoul
2025-12-09
Recruiting
Eli Lilly and Company
Phase 3
7,140
Busan, Daegu, Guri-si, Gwangju, Namdong-gu, Seongnam, Seoul, Ulsan
2025-12-01
Recruiting
Gachon University Gil Medical Center
Phase 4
64
Busan, Chungju, Daegu, Daejeon, Gwangju, Incheon, Seoul, Wŏnju
2025-11-24
Recruiting
UCB Biopharma SRL
Phase 3
320
Anyang-si, Bucheon-si, Busan, Gwangju, Jeonju, Seongnam-si, Seoul
2025-11-14
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Busan, Gwangju, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2025-11-12
Active, closed
Novo Nordisk A/S
Phase 3
330
Yangsan, Gwangju, Seoul
2025-11-05
Not yet open
Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia
NCT07247240Congenital Diaphragmatic Hernia, Pulmonary Hypertension
DrugNitric Oxide
Asan Medical Center
Phase 4
40
Seoul, Gwangju
2025-11
Recruiting
Samsung Medical Center
Not applicable
520
Gwangju, Seoul
2025-10-22
Recruiting
Samsung Medical Center
Not applicable
3,500
Bucheon-si, Daegu, Gwangju, Gwangmyeong, Ilsan, Incheon, Jeonju, Jinju
2025-10-02
Recruiting
Sanofi
Phase 3
980
Ansan-si, Busan, Daegu, Daejeon, Gwangju, Seoul, Suwon
2025-10-01
Recruiting
Eli Lilly and Company
Phase 3
1,000
Anyang-si, Bucheon-si, Busan, Gwangju, Junggu, Seoul
2025-09-30
Recruiting
Genentech, Inc.
Phase 2
224
Wŏnju, Busan, Daejeon, Gwangju, Seoul
2025-09-29
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Anyang-si, Busan, Changwon-si, Cheongju-si, Daegu, Daejeon, Goyang-si, Gwangju
2025-09-22
Recruiting
Traws Pharma, Inc.
Phase 2
90
Gwangju, Seoul, Wŏnju, Incheon
2025-09-16
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Daegu, Gwangju, Namdong-gu, Seongnam, Seoul, Suwon, Ulsan
2025-09-02
Recruiting
Pfizer
Phase 3
6,000
Chuncheon, Gwangju, Seoul, Daegu
2025-08-25
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsPRL-02·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Daegu, Gwangju, Seoul
2025-08-19
Recruiting
Chonnam National University Hospital
Not applicable
256
Busan, Daegu, Gwangju, Jeonju, Seoul, Ulsan
2025-08-18
Recruiting
NeuroBiogen Co., Ltd
Phase 2
114
Gwangju, Guri-si, Suwon, Incheon, Seoul
2025-08-06
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Ansan-si, Bucheon-si, Busan, Daejeon, Daejoen, Gwangju, Incheon, Seongnam
2025-07-22
Recruiting
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT07002164Myocardial Infarction (MI), Heart Failure
Chonnam National University Hospital
Not applicable
780
Changwon, Daegu, Daejeon, Gwangju, Jeonju, Jinju, Pusan, Seongnam
2025-07-15
Recruiting
Bristol-Myers Squibb
Phase 3
586
Gwangju, Seongnam, Seoul
2025-07-14
Recruiting
Pfizer
Phase 3
300
Namdong-gu, Gwangju, Seoul
2025-07-14
Recruiting
Asan Medical Center
Phase 4
2,340
Seoul, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon
2025-07-10
Recruiting
Incheon St.Mary's Hospital
Phase 4
160
Ansan, Busan, Chilgok, Chuncheon, Gwangju, Incheon, Seoul, Yangsan
2025-07-07
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Gwangju, Gyeonggi-do, Incheon, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-07-02
Active, closed
Mundipharma Research Limited
Phase 2
60
Gwangju, Seoul
2025-06-30
Active, closed
AbbVie
Phase 3
573
Busan, Daegu, Daejeon, Seongnam-si, Suwon, Gwangju, Seoul
2025-06-17
Recruiting
AstraZeneca
Phase 3
15,100
Bucheon-si, Busan, Changwon-si, Daegu, Daejeon, Goyang-si, Gwangju, Gwangmyeong
2025-06-04
Not yet open
Next Biomedical Co., Ltd.
Not applicable
60
Cheongju-si, Daejeon, Gwangju, Sejong, Seoul, Yangsan
2025-06
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Busan, Gwangju, Incheon, Seongnam, Seoul, Wŏnju
2025-05-20
Recruiting
Medipixel XA-Assisted PCI in Coronary Artery Disease
NCT06985693Percutaneous Coronary Intervention (PCI), Coronary Arterial Disease (CAD)
CHA University
Not applicable
830
Gwangmyeong, Seongnam-si, Daegu, Gwangju, Jeonju, Ulsan
2025-05-15
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Gwangju, Seogu, Seoul
2025-05-12
Recruiting
Hoffmann-La Roche
Phase 3
425
Ansan-si, Daegu, Gwangju, Seoul
2025-05-12
Recruiting
Samsung Medical Center
Not applicable
1,200
Ansan, Daegu, Gangneung, Goyang, Gwangju, Gwangmyeong, Incheon, Jeonju
2025-04-07
Recruiting
Gilead Sciences
Phase 3
695
Changwon-Si, Gwangju, Seongbuk-Gu, Seongnam, Seoul, Suwon, Ulsan
2025-04-04
Recruiting
Novartis Pharmaceuticals
Observational
70
Jinju, Busan, Gwangju
2025-04-02
Recruiting
AstraZeneca
Phase 3
5,000
Ansan-si, Anyang-si, Busan, Cheonan-si, Goyang-si, Gwangju, Seongnam-si, Seoul
2025-03-03
Active, closed
argenx
Phase 3
631
Anyang-si, Suwon, Gwangju, Seoul
2025-01-15
Recruiting
IRIS-Coroflex NEO Cohort
NCT06177743Coronary Artery Stenosis, Coronary Artery Disease
Seung-Jung Park
Observational
1,000
Seoul, Bucheon-si, Daegu, Gwangju, Ilsan, Sejong, Suwon, Uijeongbu-si
2025-01-09
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Seogu, Gwangju, Anyang-si, Seongnam-si, Seoul
2025-01-08
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,714
Busan, Daegu, Gwangju, Ansan-si, Anyang-si, Bucheon-si, Hwaseong-si, Seongnam-si
2024-12-18
Recruiting
Duk-Woo Park, MD
Phase 4
1,040
Bucheon-si, Changwon, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon
2024-12-18
Recruiting
Pfizer
Phase 3
2,330
Namdong-gu, Tonggu, Wŏnju, Gwangju, Ansan-si, Suwon, Dongjak-gu, Gangnam-gu
2024-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Gwangju, Seongnam-si, Seoul, Suwon
2024-12-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Wŏnju, Gwangju, Ansan-si, Jinju, Pusan, Deagu, Seoul
2024-12-02
Active, closed
Eli Lilly and Company
Phase 3
1,400
Busan, Cheongju-si, Gangnam-gu, Gangseo-gu, Gwangju, Incheon, Jeju City, Namdong-gu
2024-10-24
Recruiting
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
NCT06618638ADPKD (autosomal Dominant Polycystic Kidney Disease)
Seoul National University Hospital
Not applicable
340
Anyang-si, Seoul, Busan, Daegu, Gwangju
2024-10-21
Recruiting
AbbVie
Observational
3,000
Busan, Daejeon, Gangwon-do, Gwangju, Ansan-si, Goyang, Goyang-si, Hwaseong
2024-09-24
Active, closed
Takeda
Phase 3
2,099
Wŏnju, Gwangju, Beon-gil Bundang-gu, Bucheon-si, Gwangjin-Gu, Seocho-Gu, Seoul
2024-09-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Wŏnju, Gwangju, Seongnam, Suwon, Cheongju-si, Busan, Haeundae-gu, Daegu
2024-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Daegu, Gwangju, Seoul
2024-07-31
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Daegu, Gwangju, Seoul
2024-06-25
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bucheon-si, Busan, Cheongju-si, Daejeon, Deagu, Gwangju, Incheon, Seongnam
2024-06-17
Recruiting
Duk-Woo Park, MD
Not applicable
1,500
Bucheon-si, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon, Pusan
2024-06-14
Recruiting
LEO Pharma
Phase 3
195
Ansan-si, Gwangju, Seoul
2024-06-10
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Gwangju, Seoul
2024-05-21
Active, closed
Sanofi
Phase 3
1,541
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-gu, Seoul
2024-05-08
Recruiting
CSL Behring
Phase 2/3
3,110
Ilsan-gu, Anyang-si, Daegu, Gangnam-gu, Goyang-si, Guri-si, Gwangju, Seoul
2024-04-27
Recruiting
AstraZeneca
Phase 3
3,850
Anyang-si, Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gwangmyeong
2024-04-12
Active, closed
Amgen
Phase 3
434
Gwangju, Seoul
2024-04-08
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Anyang-si, Busan, Deagu, Gwangju, Gyeonggi-do, Seoul, Suwon
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Ansan-si, Anyang-si, Busan, Cheonan-si, Daejeon, Goyang-si, Gwangju, Seoul
2024-03-29
Recruiting
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
NCT06227754ST Elevation Myocardial Infarction, Myocardial Infarction
Chonnam National University Hospital
Not applicable
1,500
Daegu, Gwangju, Iksan, Incheon, Jeju City, Jeonju, Jinju, Seoul
2024-03-25
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Ansan-si, Anyang-si, Bucheon-si, Gwangju, Seongnam, Seoul
2024-03-09
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bucheon-si, Daegu, Daejeon, Dongjak-gu, Gwangju, Namdong-gu, Seongnam, Seoul
2024-03-05
Recruiting
Wonju Severance Christian Hospital
Not applicable
588
Gwangju, Wŏnju, Gyeonggi-do, Seoul
2024-02-22
Recruiting
AstraZeneca
Phase 3
5,250
Anyang-si, Busan, Daegu, Gwangju, Jeonju, Seoul, Uijeongbu-si, Ulsan
2024-02-21
Active, closed
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
NCT05995600Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack, Cerebrovascular Disease
DrugWarfarin
Seoul National University Hospital
Phase 4
200
Anyang, Busan, Cheongju-si, Chuncheon, Daegu, Daejeon, Guri-si, Gwangju
2024-02-20
Recruiting
Neuracle Science Co., LTD.
Phase 1/2
138
Bucheon-si, Gwangju, Ilsan, Pusan, Pyeongchon, Seongnam, Seoul, Suwon
2024-01-19
Recruiting
Colorado Prevention Center
Phase 3
5,200
Gwangju, Wŏnju, Seoul, Bucheon-si, Incheon, Daejeon, Cheongju-si, Busan
2024-01-17
Recruiting
A.Menarini Asia-Pacific Holdings Pte Ltd
Observational
4,537
Seoul, Gwangju
2023-12-20
Recruiting
Intellia Therapeutics
Phase 3
1,200
Gwangju, Seoul
2023-12-13
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Haeundae, Gwangju, Seoul, Gyeonggi-do, Incheon, Jeonju
2023-12-11
Active, closed
Cellid Co., Ltd.
Phase 3
4,000
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seoul
2023-11-27
Active, closed
Bristol-Myers Squibb
Phase 2
227
Pusan, Daejeon, Gwangju, Seongnam, Junggu, Seoul, Daegu
2023-11-07
Recruiting
CeraFlex PFO Closure System PMCF Study
NCT06120270Patent Foramen Ovale
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
180
Gwangju, Daegu, Seoul, Suwon
2023-11-03
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Gwangju, Seoul
2023-10-27
Active, closed
Yuhan Corporation
Phase 4
198
Wŏnju, Seoul, Busan, Daejeon, Gwangju, Gyeonggi-do, Incheon
2023-10-18
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Ansan-si, Gwangju, Gyeonggi-do, Seoul
2023-10-12
Recruiting
Samsung Medical Center
Not applicable
2,000
Bucheon-si, Chuncheon, Chungju, Daegu, Daejeon, Gwangju, Gwangmyeong, Ilsan
2023-10-02
Recruiting
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
NCT05812963ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction
Samsung Medical Center
Not applicable
1,400
Gwangju, Seoul
2023-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
774
Seongdong-gu, Gwangju, Seoul
2023-09-11
Recruiting
Gilead Sciences
Phase 3
402
Busan, Daegu, Gwangju, Seongnam, Seoul
2023-09-07
Recruiting
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
NCT06202027FGF23-related Hypophosphataemic Rickets and Osteomalacia
Kyowa Kirin Korea Co., Ltd.
Observational
100
Wŏnju, Suwon, Yangsan, Gwangju, Sejong, Busan, Seoul
2023-08-11
Active, closed
AbbVie
Phase 3
1,014
Cheonan-si, Gwangju, Seoul
2023-07-25
Recruiting
Pfizer
Phase 3
318
Suwon, Seoul, Gwangju
2023-05-20
Recruiting
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
NCT06088121Alzheimer's Disease, Dementia, Brain Diseases, Central Nervous System Diseases
Advanced Technology & Communications
Not applicable
180
Incheon, Gwangmyeong, Jeonju, Gwangju, Daegu, Gyeonggi-do, Daejeon, Seoul
2023-05-15
Recruiting
GlaxoSmithKline
Phase 3
138
Cheongju Chungcheongbuk-do, Gwangju, Seoul
2023-04-24
Active, closed
Alfasigma S.p.A.
Phase 3
495
Gwangju, Seoul
2023-04-05
Active, closed
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
DrugsDomvanalimab·Zimberelimab·Sacituzumab Govitecan·Nab-paclitaxel
Gilead Sciences
Phase 2
192
Cheongju-si, Goyang, Gwangju, Gyeonggi-do, Seogu, Seoul
2023-03-16
By invitation
Seung-Whan Lee, M.D., Ph.D.
Phase 4
4,000
Bucheon-si, Changwon, Cheonju, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2023-03-14
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Anyang-si, Busan, Daegu, Daejeon, Goyang-si, Gwangju, Incheon, Jeju Special
2023-02-15
Active, closed
Areteia Therapeutics
Phase 3
600
Anyang-si, Bucheon-si, Busan, Gwangju, Incheon, Jeonju, Seoul, Suwon
2023-01-30
Active, closed
Bristol-Myers Squibb
Phase 3
516
Gwangju, Suwon, Seoul
2023-01-12
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Anyang-si, Busan, Daegu, Daejeon, Goyang-si, Gwangju, Gyeonggi-do, Seongnam-si
2022-12-27
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Seongnam-si, Gwangju, Seoul, Chuncheon, Incheon, Cheonan, Daegu, Guri-si
2022-12-23
Active, closed
Amgen
Phase 3
7,297
Busan, Gwangju, Incheon, Seongnam-si, Gyeonggi-do, Seoul, Ulsan, Wonju-si, Gangwon-do
2022-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Daegu, Hwaseong-si, Suwon, Incheon, Seoul, Gwangju
2022-12-09
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Busan, Daegu, Gwangju, Seoul
2022-11-21
Active, closed
Chonnam National University Hospital
Not applicable
320
Gwangju, Gwangmyeong, Seoul
2022-11-01
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
DrugDonanemab
Eli Lilly and Company
Phase 3
1,500
Busan, Guri-si, Gwangju, Incheon, Junggu, Namdong-gu, Seongnam, Seongnam-si
2022-10-10
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Busan, Daegu, Gwangju, Gyeonggi-do, Hwaseong-si, Seoul, Suwon, Wŏnju
2022-09-19
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Busan, Daegu, Goyang-si, Gwangju, Gyeonggi-do, Seoul, Suwon
2022-09-13
Active, closed
Biogen
Phase 2/3
450
Ansan-si, Suwon, Daejeon, Gwangju, Seoul
2022-09-13
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Gwangju, Seoul
2022-09-08
Recruiting
GlaxoSmithKline
Phase 3
109
Gwangju, Jeonju, Kangwondo, Seoul, Suwon Kyunggi-do
2022-09-06
Recruiting
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
NCT05044273Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases, Myocardial Ischemia
Jung-min Ahn
Observational
2,000
Anyang, Busan, Changwon, Daegu, Gangneung, Gwangju, Iksan, Seongnam
2022-09-01
Active, closed
Sanofi
Phase 2/3
1,856
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-Gu, Seoul
2022-08-22
Recruiting
Psychopharmacotherapy for Depressive Patients
NCT06054321Major Depressive Disorder
DrugEscitalopram
Chonnam National University Hospital
Not applicable
400
Gwangju
2022-08-03
Active, closed
Drug-Coated Balloon in Patients With High Bleeding Risk
NCT05221931Coronary Artery Disease
Samsung Medical Center
Not applicable
1,359
Ansan, Cheongju-si, Daegu, Gangneung, Gwangju, Gwangmyeong, Incheon, Jinju
2022-07-29
Active, closed
PureTech
Phase 2
240
Bucheon-si, Goyang-si, Busan, Daegu, Gwangju, Gyeonggi-do, Incheon, Seoul
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Busan, Daegu, Goyang-si, Gwangju, Hwaseong-si, Seongnam-si, Seoul, Suwon
2022-07-22
Active, closed
Novartis Pharmaceuticals
Phase 3
452
Bundang Gu, Suwon, Gwangju, Seoul
2022-07-14
Active, closed
GlaxoSmithKline
Phase 3
163
Gwangju, Seoul
2022-07-14
Active, closed
ArriVent BioPharma, Inc.
Phase 1
160
Gwangju, Seoul
2022-06-30
Active, closed
Yuhan Corporation
Observational
1,219
Busan, Daegu, Gwangju, Seoul
2022-06-08
Active, closed
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003Clinical High Risk, Psychosis, Remission, Conversion
Brigham and Women's Hospital
Observational
2,617
Gwangju, Seoul
2022-06-02
Active, closed
Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)
NCT05369182Coronary Microvascular Disease, Coronary Artery Disease, Ischemic Heart Disease
Samsung Medical Center
Observational
1,003
Gwangju, Jinju, Seongnam, Seoul
2022-04-22
By invitation
AstraZeneca
Phase 3
214
Busan, Gwangju, Seoul
2022-04-19
Active, closed
Janssen Research & Development, LLC
Phase 1/2
235
Goyang-si, Gwangju, Seoul
2022-04-11
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Busan, Daegu, Gwangju, Seoul, Anyang, Hwaseong-si, Seongnam
2022-04-05
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Busan, Daegu, Gwangju, Goyang-si, Anyang, Hwasŏng, Seongnam, Seoul
2022-03-15
Recruiting
Joon Bum Kim
Phase 4
1,300
Bucheon-si, Busan, Daegu, Gangneung, Gwangju, Seongnam, Seoul, Suwon
2022-02-21
Recruiting
Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries
NCT05272618Myocardial Infarction, Coronary Microvascular Dysfunction, Vasospasm, Coronary
Chonnam National University Hospital
Observational
150
Gwangju
2022-02-14
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Busan, Daegu, Daejeon, Dongdaemun-gu, Goyang-si, Gwangju, Gyeonggi-do, Seoul
2022-01-19
Recruiting
Imaging and Physiologic Evaluation of Coronary Artery Disease
NCT05124249Ischemic Heart Disease, Atherosclerosis
Chonnam National University Hospital
Observational
2,000
Gwangju
2021-11-01
Recruiting
Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)
NCT04968808Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis, Multi Vessel Coronary Artery Disease
Chonnam National University Hospital
Not applicable
1,014
Gwangju
2021-09-06
Recruiting
Regulatory Post-Marketing Surveillance Study for Brolucizumab
NCT04985487Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals
Observational
3,000
Daegu, Goyang-si, Guri-si, Suwon, Iksan Si, Daejeon, Busan, Gwangju
2021-08-18
By invitation
BioCryst Pharmaceuticals
Phase 3
139
Daegu, Gwangju, Seoul
2021-07-23
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Cheonan-si, Gwangju, Seoul, Suwon
2021-06-17
Recruiting
Guerbet
Phase 4
2,076
Chuncheon, Gwangju, Seongnam-si, Busan, Seoul
2021-03-24
Active, closed
Novartis Pharmaceuticals
Phase 3
345
Wŏnju, Incheon, Seoul, Gwangju
2021-03-01
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Busan, Daegu, Goyang-si, Gwangju, Seoul, Yangsan
2020-12-18
Active, closed
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
NCT04414163Extranodal NK/T-cell Lymphoma, Nasal Type, Extranodal NK/T-cell Lymphoma
DrugDanburstotug
ImmuneOncia Therapeutics Inc.
Phase 2
23
Gwangju, Seoul, Ulsan
2020-10-27
Active, closed
Kyungpook National University Hospital
Phase 2
364
Daegu, Daejeon, Gwangju, Incheon, Jeonju, Seoul
2020-10-23
Active, closed
Bayer
Phase 3
402
Gwangju, Chungcheongbuk-do, Daegu, Incheon, Seoul
2020-10-20
Active, closed
Exelixis
Phase 3
575
Junggu, Goyang-si, Seongnam-si, Hwasun, Busan, Daegu, Gwangju, Seoul
2020-10-19
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Seongnam-si, Seoul, Suwon
2020-09-23
Recruiting
National Cancer Center, Korea
Phase 3
1,700
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul
2020-02-15
Active, closed
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
NCT04626882Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis
Chonnam National University Hospital
Not applicable
994
Bucheon-si, Changwon, Daegu, Gangneung, Gwangju, Jeonju, Jinju, Seoul
2019-12-30
Recruiting
Stroke Thrombectomy and Aneurysm Registry
NCT04994756Stroke, Thromboses, Intracranial, Aneurysm, Brain
Medical University of South Carolina
Observational
40,000
Gwangju
2019-09-17
Active, closed
Biogen
Observational
74
Busan, Changwon, Cheongju-si, Daegu, Daejeon, Gwangju, Jeonju, Seoul
2019-07-02
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Gwangju, Gyeonggi-do, Seoul
2019-06-11
Active, closed
SCM Lifescience Co., LTD.
Observational
42
Bucheon-si, Daegu, Goyang-si, Gwangju, Incheon, Suwon
2019-05-10
Active, closed
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763Acute Respiratory Distress Syndrome in Children
University of Pennsylvania
Not applicable
600
Gwangju
2019-05-01
Active, closed
Eisai Inc.
Phase 3
1,906
Seongnam-si, Gwangju, Busan, Incheon, Seoul
2019-03-27
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Seongnam-si, Seoul
2019-01-25
Active, closed
AstraZeneca
Phase 3
407
Daegu, Gwangju, Seoul
2018-11-27
Recruiting
Seung-Jung Park
Observational
500
Bucheon-si, Daegu, Daejeon, Gwangju, Pusan, Seongnam, Seoul
2018-09-04
Active, closed
Gilead Sciences
Phase 2
502
Daegu, Goyang-si, Gwangju, Hwasun, Seongbuk-Gu, Seoul, Suwon, Wŏnju
2018-08-13
Active, closed
Seung-Jung Park
Not applicable
2,008
Daegu, Daejeon, Gwangju, Pusan, Seoul
2018-04-12
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Daejeon, Gwangju, Gyeonggi-do, Seoul, Yangsan
2018-04-05
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Busan, Daejeon, Goyang-si, Gwangju, Gyeonggi-do, Incheon, Seoul, Wŏnju
2018-03-23
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Daejeon, Gwangju, Jeonju, Seoul, Suwon, Ulsan
2016-12
Recruiting
Kee-joon Choi
Phase 4
140
Bucheon-si, Busan, Cheonan, Daegu, Daejeon, Gangneung, Gwangju, Iksan
2016-11-29
Active, closed
IRIS-Synergy Cohort in the IRIS-DES Registry
NCT02720419Coronary Artery Disease
Jung-min Ahn
Observational
3,000
Bucheon-si, Busan, Cheonan, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2016-08
Active, closed
Tesaro, Inc.
Phase 1
729
Changwon, Gwangju, Seongnam-si, Seongnam-si Gyeonggi-do, Seoul
2016-03-07
Active, closed
AbbVie
Phase 3
1,629
Daegu, Junggu, Gwangju, Seongdong-gu, Seoul
2015-12-01
Active, closed
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
NCT02112214Gastric Cancer, Helicobacter Pylori Infection
National Cancer Center, Korea
Phase 3
5,224
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul, Uijeongbu-si
2014-06
Recruiting
Drug-Eluting Balloon Registry in Routine Clinical Practice
NCT02038660Coronary Artery Disease, Angioplasty, Balloon
Seung-Jung Park
Observational
1,500
Bucheon-si, Daegu, Daejeon, Gwangju, Pusan, Seoul, Ulsan
2014-01
Active, closed
Comprehensive Nano - Post Market Clinical Follow-Up Study
NCT03423953Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Revision
Zimmer Biomet
Observational
194
Gwangju, Seoul
2013-10-30
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Daegu, Gwangju, Pusan, Seongnam, Seoul
2013-10-14
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Dongan, Seoul, Anyang-si, Goyang-si, Daegu, Gwangju, Gyeonggi-do, Jeju-do
2013-03-18
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Yangsan, Busan, Changwon, Cheongju-si, Daegu, Daejeon, Gangneung, Gwangju
2012-01
Recruiting
Seung-Jung Park
Observational
20,000
Anyang, Bucheon-si, Cheongju-si, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2011-06
Active, closed
Acute Myocardial Infarction in Cancer Patients
NCT06281054Acute Myocardial Infarction, Cancer
Samsung Medical Center
Observational
4,500,000
Gwangju
2002-01-01
Recruiting
Medtronic
Observational
20,000
Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gyeonggi-do, Jeonju, Seongnam-si
1983-01
Rows per page Showing 1–206 of 206
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/gwangju

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 206 of those studies with a site in Gwangju.

How many clinical trials are recruiting in Gwangju?

108 of the 206 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 10 have not yet opened recruitment, 84 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gwangju), 206 studies
PhaseStudiesRecruitingShare
Phase 31045150.5%
Not applicable311915%
Observational302114.6%
Phase 22089.7%
Phase 41275.8%
Phase 2/3411.9%
Phase 1/2311.5%
Phase 1201%

Most active sponsors

Lead sponsors with the most studies (Gwangju)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC171
Chonnam National University Hospital149
Eli Lilly and Company118
Novartis Pharmaceuticals116
Samsung Medical Center106
AstraZeneca96
Seung-Jung Park65
Boehringer Ingelheim54
Hoffmann-La Roche54
Sanofi53
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.